Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download whole issue [PDF]

Contents – 2023, Vol. 32, No. 8 (August)

1

Editorial

Identifying drug interactions using machine learning

829-838

2

Meta-analysis

Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis

839-845

3

Original Article

The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery

847-853

4

Original Article

The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants

855-863

5

Original Article

Allogeneic platelet gel therapy for refractory abdominal wound healing: A preliminary study

865-872

6

Original Article

Serum levels of SOCS6 are decreased in diabetic retinopathy and are related to severity of the disease

873-880

7

Original Article

Favipiravir-induced inflammatory and hydropic degenerative liver injury in rats

881-887

8

Original Article

The time-dependent adverse effects of a high-fat diet on sperm parameters

889-900

9

Original Article

The contribution of donated human embryos suitable for the production of embryonic stem cells to increase the quality of life: Selection and preparation of embryos in the Czech Republic

901-907

10

Original Article

Alpha-solanine inhibits endothelial inflammation via nuclear factor kappa B signaling pathway

909-920

11

Review

Bone tissue 3D bioprinting in regenerative dentistry through the perspective of the diamond concept of healing: A narrative review

921-931